Pages that link to "Q41214134"
Jump to navigation
Jump to search
The following pages link to Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle (Q41214134):
Displaying 50 items.
- Efficacy and Safety Limitations of Attention-Deficit Hyperactivity Disorder Pharmacotherapy in Children and Adults (Q22241427) (← links)
- Methylphenidate and its Isomers (Q22241429) (← links)
- Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis (Q22252430) (← links)
- Alpha2 adrenergic agonists for attention deficit hyperactivity disorder (ADHD) (Q24201757) (← links)
- Social skills training for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years (Q24234231) (← links)
- Social skills training for children with attention deficit hyperactivity disorder (ADHD) (Q24239933) (← links)
- Tricyclic antidepressants for ADHD in children and adolescents (Q24243688) (← links)
- Methylphenidate for attention-deficit/hyperactivity disorder in adults (Q24245615) (← links)
- A review of complementary and alternative treatments for autism spectrum disorders (Q24603000) (← links)
- Emerging support for a role of exercise in attention-deficit/hyperactivity disorder intervention planning (Q26866477) (← links)
- Pharmacotherapy of adolescent attention deficit hyperactivity disorder: challenges, choices and caveats (Q28138163) (← links)
- Stimulant drugs (Q28141748) (← links)
- Assessment and treatment of attention deficit hyperactivity disorder in children with comorbid psychiatric illness (Q28204939) (← links)
- Pharmacological treatment of adult ADHD in Europe (Q28247634) (← links)
- Nutritional supplements for the treatment of ADHD (Q28247932) (← links)
- Attention-deficit/hyperactivity disorder in adults: evidence-based recommendations for management (Q28295525) (← links)
- How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis (Q28344196) (← links)
- Methylphenidate in the treatment of children with attention-deficit hyperactivity disorder (Q28344200) (← links)
- A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder (Q28369763) (← links)
- Uso de amitriptilina na síndrome de hiperatividade com déficit de atenção (Q29307302) (← links)
- Attention-deficit/hyperactivity disorder in preschoolers. Does it exist and should we treat it? (Q30304472) (← links)
- Sex differences in effectiveness of extended-release stimulant medication among adolescents with attention-deficit/hyperactivity disorder (Q30448342) (← links)
- Quantifying the relationship between perceived consequences of ADHD medication and its usage (Q30455992) (← links)
- Predicting acute side effects of stimulant medication in pediatric attention deficit/hyperactivity disorder: data from quantitative electroencephalography, event-related potentials, and a continuous-performance test (Q30667435) (← links)
- Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research (Q30676289) (← links)
- Predicting the clinical outcome of stimulant medication in pediatric attention-deficit/hyperactivity disorder: data from quantitative electroencephalography, event-related potentials, and a go/no-go test (Q30756332) (← links)
- New formulations of stimulants for attention-deficit hyperactivity disorder: therapeutic potential (Q33209665) (← links)
- Dyssomnia in children diagnosed with attention deficit hyperactivity disorder: a critical review (Q33214503) (← links)
- Baduk (the Game of Go) Improved Cognitive Function and Brain Activity in Children with Attention Deficit Hyperactivity Disorder (Q33620357) (← links)
- A search for the evidence supporting community paediatric practice (Q33634069) (← links)
- Stimulant drug response in the predominantly inattentive and combined subtypes of attention-deficit/hyperactivity disorder (Q33694945) (← links)
- Treatment Patterns among Children and Adolescents with Attention-Deficit/Hyperactivity Disorder with or without Psychiatric or Neurologic Comorbidities in Sweden: A Retrospective Cohort Study (Q33736227) (← links)
- Treating attention-deficit/hyperactivity disorder beyond symptom control alone in children and adolescents: a review of the potential benefits of long-acting stimulants (Q33746664) (← links)
- Attention-deficit/hyperactivity disorder and comorbidity (Q33778177) (← links)
- Alternative (nonstimulant) medications in the treatment of attention-deficit/hyperactivity disorder in children (Q33778193) (← links)
- Fact versus fancy concerning the multimodal treatment study for attention-deficit hyperactivity disorder (Q33819006) (← links)
- Attention-deficit hyperactivity disorder in children and youth: a quantitative systematic review of the efficacy of different management strategies (Q33819024) (← links)
- Randomized, placebo-controlled, crossover study of methylphenidate for attention-deficit/hyperactivity disorder symptoms in preschoolers with developmental disorders (Q33819940) (← links)
- Clinical psychopharmacology of AD/HD: implications for animal models. (Q33827976) (← links)
- Attention deficit-hyperactivity disorder and its deceivers (Q33854498) (← links)
- Relation between therapeutic response and side effects induced by methylphenidate as observed by parents and teachers of children with ADHD. (Q33879098) (← links)
- Joint analysis of the DRD5 marker concludes association with attention-deficit/hyperactivity disorder confined to the predominantly inattentive and combined subtypes (Q33909673) (← links)
- Attention-deficit/hyperactivity disorder in adults: an overview (Q33911442) (← links)
- Present and future pharmacotherapeutic options for adult attention deficit/hyperactivity disorder (Q33945438) (← links)
- The stimulants revisited. (Q34005063) (← links)
- Lisdexamfetamine: a prodrug for the treatment of attention-deficit/hyperactivity disorder (Q34020034) (← links)
- Clinical suggestions for management of stimulant treatment in adolescents (Q34086794) (← links)
- Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder (Q34101600) (← links)
- Current concepts and controversies in the diagnosis and treatment of attention deficit hyperactivity disorder (Q34108317) (← links)
- Non-stimulant treatments for ADHD. (Q34120068) (← links)